(Health-NewsWire.Net, January 22, 2016 ) DelveInsight Report, “Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2016” emphasizes on the currently active CAR-T cell products in research and development. The Report covers the 40+ companies which are active in this field including 27 leading companies with 101 products targeting 44 different antigens and 24 different technologies. The Report provides in-depth analysis on the CAR-T cell profiles covering pre-clinical and clinical studies, Collaborations details and Deal values, Technologies and Targeted antigens. The Report provides the CAR-T licensing opportunities, acquisitions, market drivers and barriers followed by SWOT Analysis. Report also describes the unmet needs covered by CAR-T cells highlighting the adverse events, which are major concerns in the market for the usage of CAR-T cells.
Report Highlights:
CAR-T cell Therapy Pipeline scenario Collaborations & partnering deals Current Prominent Research Areas and Key Players Pipeline product profiles CAR-T Technologies and Targeted Antigens Licensing opportunities Market Drivers and Barriers
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=522288
Scope
Overview of the global CAR-T cell therapy pipeline scenario, products and associated companies information Coverage of global CAR-T cell therapies under development Competitive landscape of products for key players and related indications Coverage of licensors, collaborators and Development partners, deal terms and deal values estimation Pipeline analysis across different phases, emerging trends and comparative analysis of pipeline products with detailed clinical profiles, mechanism of action, route of administration and molecule type, along with product development activities Highlights of licensing & collaboration opportunities and funding details Highlights of latest CAR-T technologies and innovative companies Key topics covered include strategic competitor assessment, barriers and drivers in the market along with SWOT analysis
Reason to buy
Pipeline intelligence and complete understanding over therapeutics development of CAR-T cell products to exploit opportunities Explore outcomes of Pre-clinical and clinical studies and Identify prominent therapeutic areas Develop & design strategies to gain competitive advantage by tracking the latest CAR-T technologies and associated innovative companies Track in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope Uncovering opportunities in the rapidly growing market, Optimize portfolio, keep updated and make the best decisions for business development Identifying the upcoming leaders and products in the CAR-T cell therapy market in the coming years Understand the CAR-T competitive landscape, plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Browse Detail Report With TOC @ http://www.researchmoz.us/chimeric-antigen-receptor-car-t-cell-immunotherapy-competitive-landscape-technology-and-pipeline-analysis-2016-report.html
Table of Contents
1 Report Introduction
2 Executive Summary Snapshot
3 Executive Summary
4 Introduction 4.1. Chimeric antigen receptor (CAR) T-cells 4.2. History 4.3. CARs and Generations 4.4. Advantages of CAR-T cells 4.5. Adverse Events with CAR T-cell Therapy
5 CAR-T Cell Therapy-Analysis 5.1. CAR-T Collaboration Deals 5.1.1. CAR-T Cells Therapy Collaborations and Deal Year 5.1.2. Collaborations & Deal Value Trends 5.1.4. Companies collaborations for future developments 5.2. CAR-T Acquisitions Deals 5.2.1. CAR-T Cells Therapy Acquisitions Trends 5.2.2. CAR-T Cells Therapy Acquisitions Offerings by Big Giants 5.3. New facilityfor the development of CAR-T cells 5.4. CAR-T Licensing Opportunities 5.5. Pipeline Scenario 5.5.1. Pipeline Products under Development-An Overview 5.5.2. Pipeline Products under Development by Company 5.5.3. CAR T-cells Therapeutic Areas & Companies 5.5.4. CAR-T cells Targeted Antigens 5.5.5. CAR-T Therapies-Clinical trials & Completion Year 5.5.6. CAR T-cell Technologies & Companies Involved 5.5.7. CAR-T Safety Switches & Company involved 5.5.8. Companies with Upcoming CAR-T Therapeutics
6 Pipeline Profiles
7 Upcoming Technologies Better than CARs
8 Market Drivers
9 Market Barriers
10 SWOT Analysis
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=522288
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz Mr. Nachiket Ghumare, Tel: +1-518-621-2074 USA-Canada Toll Free: 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/
Browse Our Latest Press Releases @ http://www.researchmoz.us/pressrelease
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com
|